Records containing: Macular Degeneration
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-23A Randomized Double-masked, Multicenter, 3-arm, Pivotal Phase 2/3 Study to Evaluate the Efficacy and Safety of Intravitreal (IVT) EYE201/MK-8748 Compared to Aflibercept (2 mg) in Participants With Neovascular Age-related Macular Degeneration (NVAMD)
-
CLINICAL_TRIALS study record update · 2026-04-22A Randomized Double-masked, Multicenter, 3-arm, Pivotal Phase 2/3 Study to Evaluate the Efficacy and Safety of Intravitreal (IVT) EYE201/MK-8748 Compared to Aflibercept (2 mg) in Participants With Neovascular Age-related Macular Degeneration (NVAMD)
-
CLINICAL_TRIALS study record update · 2026-04-21A Non-interventional, Observational Study to Evaluate Treatment Patterns and Safety of Avacincaptad Pegol (ACP/IZERVAY™) in Routine Clinical Practice in Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration
-
CLINICAL_TRIALS study record update · 2026-04-20Ocular Imaging Study Using Advanced OCT
-
CLINICAL_TRIALS study record update · 2026-04-13Long-term Extension Study for Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD) in JNJ-81201887 Parent Clinical Studies
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-04-13A Randomized, Double Masked, Parallel Group, Dose-finding Study to Evaluate SYL1801 in Patients With Neovascular AMD
-
CLINICAL_TRIALS study record update · 2026-04-01Development and Validation of an Artificial Intelligence-assisted Diagnostic System for Ophthalmic Pathologies
-
CLINICAL_TRIALS study record update · 2026-02-09Characterization of Multiple Factors in Training and Plasticity in Central Vision Loss: Healthy Vision
-
CLINICAL_TRIALS study record update · 2026-02-09Characterization of Multiple Factors in Training and Plasticity in Central Vision Loss: Macular Degeneration
-
CLINICAL_TRIALS study record update · 2026-02-04A Three-part, Phase I/II Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of Zifibancimig Following Intravitreal Administration of Multiple Ascending Doses and Continuous Delivery From the Port Delivery in Patients With Neovascular Age-related Macular Degeneration
-
CLINICAL_TRIALS study record update · 2026-02-04A Pilot Study to Assess the Feasibility and Safety of MB-102 in Ocular Angiography as Compared to Fluorescein Sodium
-
CLINICAL_TRIALS study record update · 2026-01-27A Phase IV, Prospective, Open-label, Single-arm Clinical Trial to Evaluate the Efficacy of Faricimab and Biomarker Assessment in Patients With Neovascular Age-related Macular Degeneration
-
CLINICAL_TRIALS study record update · 2026-01-22Improving Vision in Adults With Macular Degeneration, Study 2: The Effect of Concurrent Perceptual Learning and Brain Stimulation
-
CLINICAL_TRIALS study record update · 2025-12-10Color Vision Loss Progression in IRD Patients: Retinal Structural Changes Correlations, and a Novel Color Discrimination Test for Extreme Low Vision Patients
-
CLINICAL_TRIALS study record update · 2025-11-20A Single and Multiple Dose Study to Evaluate Safety, Pharmacokinetics, and Treatment Effect of Intravitreal AVD-104 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
-
CLINICAL_TRIALS study record update · 2025-10-24New Methods to Quantify and Train Eye Movement Strategies in Macular Degeneration
-
CLINICAL_TRIALS study record update · 2025-10-15Remapping Text in Sentence and Word Tasks to Aid Reading With Central Vision Loss
-
CLINICAL_TRIALS study record update · 2025-08-24FOCUS: An Open Label First in Human Phase I/II Multicentre Study to Evaluate the Safety, Dose Response and Efficacy of GT005 Administered as a Single Subretinal Injection in Subjects With Macular Atrophy Due to AMD
-
CLINICAL_TRIALS study record update · 2025-06-13A Multicentre, Natural History, Non-interventional Study Evaluating Biomarkers In Participants With Geographic Atrophy(GA) Secondary To Age-Related Macular Degeneration (AMD)
-
CLINICAL_TRIALS study record update · 2025-06-06Randomized, Double-blind, Parallel, Active Controlled Study to Compare Efficacy & Safety Between Ranibizumab 10mg/ml Injection of Incepta and Lucentis in Patients With Diabetic Macular Edema by ITV Injection
-
CLINICAL_TRIALS study record update · 2025-04-17Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for the Treatment of Non-arteritic Ischemic Optic Neuropathy
-
CLINICAL_TRIALS study record update · 2025-03-24A Prospective Observational Study to Assess the Reliability and Validity of the Multi-Luminance Shape Discrimination Test (MLSDT) With 9 Objects
-
CLINICAL_TRIALS study record update · 2025-03-24Implementation of the Intravitreal Injection Service Administered by Nurses: Safety and Satisfaction of the Patients Served
-
CLINICAL_TRIALS study record update · 2025-03-20Bone Marrow Derived Stem Cell Ophthalmology Treatment Study II
-
CLINICAL_TRIALS study record update · 2025-03-07A Phase 2, Randomized Placebo-Controlled, Double-Masked Study to Assess Safety and Efficacy of Multiple Doses of IONIS-FB-LRx, an Antisense Inhibitor of Complement Factor B, in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration (AMD)